Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1556509
This article is part of the Research Topic Harnessing Molecular Insights for Enhanced Drug Sensitivity and Immunotherapy in Cancer View all 18 articles

Zinc finger protein ZC3H18 is abnormally expressed in esophageal cancer tissues and facilitates the proliferation of esophageal cancer cells

Provisionally accepted
Yujin Zhang# Yujin Zhang# Yilong Wan Yilong Wan Jiaxi Li Jiaxi Li Sheng Ju Sheng Ju *Xin Tong Xin Tong Ji Wu Ji Wu Hao Wu Hao Wu Liuqing Zhang Liuqing Zhang Shengxiang Shao Shengxiang Shao Yuhong Wang Yuhong Wang Lingchuan Guo Lingchuan Guo Jun Zhao Jun Zhao Dong Jiang Dong Jiang *Lei Cao Lei Cao *
  • Soochow University, Suzhou, China

The final, formatted version of the article will be published soon.

    Esophageal cancer presents significant challenges due to the limited efficacy and severe side effects associated with conventional treatments. The identification of epigenetic regulatory molecules that are aberrantly expressed in tumors is crucial for elucidating the mechanisms underlying the development and progression of esophageal cancer. We performed high-throughput methylation level analysis on cancerous and adjacent tissues from 25 patients, identifying the differentially methylated gene ZC3H18 utilizing Bismark software and data from TCGA. Esophageal cancer cell lines with ZC3H18 knockdown were used to validate the biological role of ZC3H18 in tumorigenesis in vitro and in vivo. Eukaryotic transcriptome sequencing analysis was conducted to investigate the potential mechanisms underlying ZC3H18 function. We identified 30 genes exhibiting significant methylation differences between cancerous and adjacent noncancerous tissues in 25 patients. Subsequent analysis utilizing the TCGA database revealed that the gene ZC3H18 is aberrantly expressed in tumor tissues and is closely associated with patient prognosis.Examination of esophageal cancer tissue samples demonstrated overexpression of the ZC3H18 protein, which was positively correlated with adverse prognosis indicators, including tumor differentiation, stage, and invasion depth. ZC3H18 knockdown significantly inhibited cellular proliferation, migration, invasion, and damage repair. Additionally, ZC3H18 significantly promoted tumor growth in vivo. The expression of various cytokeratins was significantly reduced following the ZC3H18 gene knockdown. ZC3H18 and multiple keratins were co-localized in esophageal cancer tissue. ZC3H18 gene exhibits differential methylation in esophageal cancer was positively correlated with unfavorable patient prognosis. ZC3H18 plays a critical role in the regulation of biological functions within esophageal tumors.

    Keywords: esophageal cance, ZC3H18, Tumor growth, cytokeratin, Methylation

    Received: 07 Jan 2025; Accepted: 03 Feb 2025.

    Copyright: © 2025 Zhang#, Wan, Li, Ju, Tong, Wu, Wu, Zhang, Shao, Wang, Guo, Zhao, Jiang and Cao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Sheng Ju, Soochow University, Suzhou, China
    Dong Jiang, Soochow University, Suzhou, China
    Lei Cao, Soochow University, Suzhou, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.